The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study

NCT05003414 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-29

No results posted yet for this study

Summary

This is a Post-Marketing Surveillance study of GMK Sphere cementless knee prosthesis.

Conditions

Interventions

DEVICE

GMK Sphere cementless Knee Replacement

Performance of Total Knee Arthroplasty (TKA) with GMK Sphere cementless Knee Replacement

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Principal Investigators

  • Emmanuel Marchetti, MD · Clinique Saint Vincent de Paul

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-14
Primary Completion
2030-01-31
Completion
2032-12-31

Countries

  • France
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05003414 on ClinicalTrials.gov